Company profile
Annual Report 2013
LEI
cee stock exchange group
Issuers / Issuers News
Article print

13 Sep 2013 14:15 
Extraordinary Information
Marketing authorisation for biosimilar infliximab in EU
Attached documents:
Releaser: EGIS Pharmaceuticals PLC
Date Issued: 13 Sep 2013
 
Actual
2015 average
Name
Price
%
Turn. (tEUR)
-
915
0.00
0
-
174
0.00
0
-
56
0.00
0
-
189
0.00
0
-
5,645
0.00
0
-
789
0.00
0
-
12,305
0.00
0
-
382
0.00
0
-
4,345
0.00
0
-
306
0.00
0
-
1,181
0.00
0
-
4,000
0.00
0
-
119
0.00
0
-
4,950
0.00
0
Change %: to baseprice
Data delayed by 15 minutes
Indices
Index
Value
Change %
BUX
1,209.79
-5.44 (-0.45)
1,204.83
-4.42 (-0.37)